{
  "created_at": "2018-08-03T20:43:41.000Z",
  "updated_at": "2021-01-06T08:24:30.120Z",
  "id": "c5c485b3-4538-4059-ac52-79b04e5be76a",
  "labels": "current-affairs,2018-08-04",
  "question": "The vaccine, mycobacterium indicus pranii (MIP), which has been developed in India, is associated with prevention of which disease?",
  "option1": "Tuberculosis",
  "option2": "Diphtheria",
  "option3": "Leprosy",
  "option4": "Pneumonia",
  "option5": "",
  "answer": "Leprosy",
  "explanation": "Mycobacterium Indicus Pranii (MIP) is the world&rsquo;s first vaccine developed in India for prevention of leprosy, and India will be the first to have a large-scale vaccination programme.&nbsp; The vaccine has been developed by G P Talwar of National Institute of Immunology and has been approved by the Drug Controller General of India (DCGI) and the US-FDA. About 60% of the global leprosy patients live in India. The vaccine will help in eradicating the menace of Leprosy in India. The vaccine is now being used as a part of pilot programme in few districts of India, and if shows satisfactory&nbsp;results, the programme will be implemented in other&nbsp;high-prevalence districts across the country."
}